You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

HIQA publishes advice to NPHET on Covid-19 testing and restrictions

By Dermot - 04th Nov 2020 | 4 views

HIQA has today published the advice it submitted to the National Public Health Expert Team (NPHET) to support its response to COVID-19. The publication of this advice is accompanied by supporting evidence synthesis reports.

Current recommendations in Ireland are that close contacts of a COVID-19 case should be tested for COVID-19 and restrict their movements for 14 days. NPHET asked HIQA to undertake an evidence synthesis to identify if the current evidence supports this duration remaining at 14 days.

HIQA examined the available evidence on the incubation period (the time from exposure to symptom onset) of COVID-19. The review of the incubation period concluded that in the absence of testing, a 14-day period of restriction of movements is likely to capture 95 per cent of individuals who will become symptomatic.

Dr Máirín Ryan, HIQA’s Director of Health Technology Assessment and Deputy Chief Executive, said: “Without changes to the current testing strategy, we advised NPHET that the 14-day period of restriction of movements should remain. It is essential that people who are exposed or potentially exposed to COVID-19 restrict their movements to minimise community transmission as it has been shown that people with no symptoms can spread the infection.”

NPHET also asked HIQA to explore the potential impact of testing to reduce the period of restricted movements for close contacts of a COVID-19 case from 14 days. Based upon a modelling exercise, HIQA’s advice concluded that any testing strategy to reduce the period of restricted movements from 14 days presents an increased risk of transmission. An increased risk in transmission may not be acceptable when considering current levels of community transmission in Ireland.

Dr Ryan said: “If, at a later stage in the response, changes are made to the current testing strategy for those restricting movements, these changes need to come with a clear communication strategy. It is important that people understand the reasons for the two tests and the implications of receiving a ‘not detected’ first test result, as many people at this early stage may still be in the incubation phase of the disease. Irrespective of any changes, it is vital that people continue to adhere to all COVID-19 public health guidance.” The documents published today are available at

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]